600
Views
2
CrossRef citations to date
0
Altmetric
Author’s views

ARF6 controls RHOB targeting to endosomes regulating cancer cell invasion

ORCID Icon, , &
Article: 1766932 | Received 20 Apr 2020, Accepted 05 May 2020, Published online: 23 Jun 2020

Figures & data

Figure 1. Mechanisms though which ARF6-RHOB regulates breast cancer cell invasion. (a) ARF6 interacts with RHOB. The interaction requires the tripeptide “GCI” (glycine, cysteine, and, isoleucine) residues (188–190) of RHOB and the effector domain regions, Switch I and Switch II (28–73) of ARF6. ARF6 is essential for RHOB protein stability and the regulation of its subcellular localization. Specific targeting of ARF6 to the plasma membrane or endosomal vesicle promotes the recruitment and colocalization of RHOB to these membrane microdomains, thereby controlling cell adhesion by increasing focal adhesion (FA) formation. (b) ARF6 depletion promotes the loss of RHOB from endosomal vesicles and plasma membrane, leading to RHOB degradation. Inhibition of ARF6-RHOB complexes reduces stress fiber formation, increases FA dynamics, promoting breast cancer cell invasion.

Figure 1. Mechanisms though which ARF6-RHOB regulates breast cancer cell invasion. (a) ARF6 interacts with RHOB. The interaction requires the tripeptide “GCI” (glycine, cysteine, and, isoleucine) residues (188–190) of RHOB and the effector domain regions, Switch I and Switch II (28–73) of ARF6. ARF6 is essential for RHOB protein stability and the regulation of its subcellular localization. Specific targeting of ARF6 to the plasma membrane or endosomal vesicle promotes the recruitment and colocalization of RHOB to these membrane microdomains, thereby controlling cell adhesion by increasing focal adhesion (FA) formation. (b) ARF6 depletion promotes the loss of RHOB from endosomal vesicles and plasma membrane, leading to RHOB degradation. Inhibition of ARF6-RHOB complexes reduces stress fiber formation, increases FA dynamics, promoting breast cancer cell invasion.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.